Divis Laboratories Ltd reported INR7.51B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Alaunos Therapeutics USD -1.01M 153K Mar/2026
Aurobindo Pharma INR 9.21B 109.7M Mar/2026
Avita Medical AUD -11.62M 1.7M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Divis Laboratories Ltd INR 7.51B 1.68B Mar/2026
Ionis Pharmaceuticals USD -93M 136M Mar/2026
IQVIA Holdings USD 274M 240M Mar/2026
Lupin INR 14.6B 2.85B Mar/2026
Moderna USD -1.34B 517M Mar/2026
Organon & Co USD -205M 365M Dec/2025
Revvity USD 40.72M 57.65M Mar/2026
Tectonic Therapeutic USD -19.23M 186K Dec/2025
Tilray USD -44.93M 44.61M Sep/2025
Viatris USD 176.4M 516.5M Mar/2026
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025